VPC-13789 is a highly potent, selective, and orally bioavailable antiandrogen compound that shows promise for studying and developing therapeutics for castration-resistant prostate cancer (CRPC). In LNCaP cells, VPC-13789 effectively inhibits the transcriptional activity of the androgen receptor (AR) with an IC50 value of 0.19 µM [1].
Molekulargewicht:
383.37
CAS Nummer:
[2761146-51-2]
Formel:
C21H16F3N3O
Target-Kategorie:
Others|||Androgen Receptor
T61653
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten